Braskem S.A.(BAK)Earnings, Financials & Key Ratios
BAK•NYSE
$2.48
Price updated Jun 27, 2026
AboutBraskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells chemicals, including ethylene, polymer and chemical grade propylene, butadiene, butene-1, benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins. This segment also produces and sells polyethylene (PE) and polypropylene (PP); supplies electricity and other inputs to second-generation producers; produces and sells of PE, including the production of green PE from renewable resources; and produces and sells polyvinyl chloride and caustic soda. The United States and Europe segment produces and sells PP in the United States and Germany. The Mexico segment produces and sells ethylene, high-density PE, and low-density PE in Mexico. It also manufactures, sells, imports, and exports chemicals, petrochemicals, and fules; produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases; and provides industrial services. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in Camaçari, Brazil.Show more
- Revenue$69.33B-10.4%
- EBITDA$631M-86.8%
- Net Income-$9.69B+14.4%
- EPS (Diluted)-24.32+14.4%
- Gross Margin2.2%-71.6%
- EBITDA Margin0.91%-85.2%
- Operating Margin-5.7%-535.8%
- Net Margin-13.97%+4.5%
BAK Price & Volume
Braskem S.A. (BAK) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Losses Threaten Long-term Solvency
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Insolvency and Legal Liabilities
"Braskem faces a precarious outlook characterized by structural margin compression and a rapidly eroding equity base, which has shifted from $4.0 billion in 2023Q4 to a negative $15.5 billion by 2026Q1. The company's reliance on capital-intensive operations amidst declining demand, evidenced by a 20.4% year-over-year revenue contraction in 2026Q1, suggests that the current business model is fundamentally unsustainable. Investors should exercise extreme caution as mounting legal liabilities and persistent negative free cash flow continue to deplete the firm's liquidity buffer."
Verdict Logic
the company's inability to generate positive free cash flow, highlighted by a $4.8 billion burn in 2026Q1, combined with a negative equity position of $15.5 billion, presents an unacceptable level of insolvency risk.
BAK Growth Metrics
Braskem S.A. (BAK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years3.9%
5 Years3.44%
3 Years-10.44%
TTM-15.46%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM1.56%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-0.28%
Return on Capital
10 Years19.96%
5 Years14.1%
3 Years-2.7%
Last Year-6.87%
BAK Recent Earnings
Braskem S.A. (BAK) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (73%)●Beat Revenue 4/12 qtrs (36%)
Q2 2026Latest
May 14, 2026Metric
Actual
Est
EPS
$0.69+234.5%
$0.21
Rev
$3.1B-9.0%
$3.4B
Q2 2026
May 11, 2026Metric
Actual
Est
EPS
$0.73+330.3%
$0.32
Rev
$3.5B+4.5%
$3.4B
Q2 2026
Mar 27, 2026Metric
Actual
Est
EPS
$0.48+51.0%
$0.98
Rev
$3.1B-1.2%
$3.1B
Q4 2025
Nov 11, 2025Metric
Actual
Est
EPS
$0.02+95.8%
$0.48
Rev
$3.2B-2.0%
$3.3B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 14, 2026 | $0.69vs $0.21+234.5% | $3.1Bvs $3.4B-9.0% |
| Q2 2026 | May 11, 2026 | $0.73vs $0.32+330.3% | $3.5Bvs $3.4B+4.5% |
| Q2 2026 | Mar 27, 2026 | $0.48vs $0.98+51.0% | $3.1Bvs $3.1B-1.2% |
| Q4 2025 | Nov 11, 2025 | $0.02vs $0.48+95.8% | $3.2Bvs $3.3B-2.0% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Braskem S.A. (BAK)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.48 | $988.24M | -0.53 | -10.44% | -13.97% | — | — | |
| $55.73 | $17.95B | -23.71 | -25.18% | -3.44% | -7.2% | — | |
| $76.62 | $9.81B | -6.53 | -8.01% | -14.91% | -16.76% | — | |
| $21.73 | $2.47B | -58.73 | 3.68% | -1.89% | -6.64% | — | |
| $6.69 | $1.07B | -2.25 | -5.73% | -12.3% | -30.42% | — | |
| $37.91 | $3.48B | 42.60 | 0.61% | 4.81% | 6.6% | — |
Compare BAK vs Peers
Braskem S.A. (BAK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when BAK posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BAK Frequently Asked Questions
Braskem S.A. (BAK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Braskem S.A.'s revenue?
Braskem S.A. (BAK) reported $66.75B in revenue for fiscal year 2025. This represents a 5217% increase from $1.26B in 1998.
How fast is Braskem S.A. growing?
Braskem S.A. (BAK) saw revenue decline by 10.4% over the past year.
Is BAK profitable?
Braskem S.A. (BAK) reported a net loss of $9.13B for fiscal year 2025.
Dividend & Returns
What is Braskem S.A.'s free cash flow?
Braskem S.A. (BAK) had negative free cash flow of $9.20B in fiscal year 2025, likely due to heavy capital investments.